Amisulpride Completed Phase 4 Trials for Schizophrenic Disorders / Schizophrenia and Disorders With Psychotic Features / Schizoaffective Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02307396Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
NCT01609153Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy
NCT00245674SOLIACS: Solian Solution in the Acute Setting
NCT00304616SWitching to Abilify Trial (SWAT)
NCT00331981Amisulpride in Schizophrenic Patients
NCT00436371Amisulpride in Schizophrenic Acute Phase Patients
NCT00761670Efficacy Study on Cognitive Functions in Schizophrenic Patients
NCT01246232Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia
NCT01795183Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia